The fact that both companies operate in highly competitive industries may have capped the interest somewhat, although syndicate analysts argue that both of them have advantages over their peers that is helping to preserve margins.
Wuyi Pharmaceutical, which was the smaller of the two deals, fixed the price of its offering at the top end of the HK$1.20 to HK$1.80 range for a total deal size of HK$801.3 million $103 million. The price came after institutional...
¬ Haymarket Media Limited. All rights reserved.
